Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience

Background Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on peopl...

Full description

Bibliographic Details
Main Authors: Tina Chisenga, Menard Chihana, Paul Chishimba, Lastone Chitembo, Lloyd Mulenga, Andrew Silumesii, David Maman, Cheryl Johnson
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Global Health Action
Subjects:
Online Access:http://dx.doi.org/10.1080/16549716.2023.2175992
_version_ 1797351918594424832
author Tina Chisenga
Menard Chihana
Paul Chishimba
Lastone Chitembo
Lloyd Mulenga
Andrew Silumesii
David Maman
Cheryl Johnson
author_facet Tina Chisenga
Menard Chihana
Paul Chishimba
Lastone Chitembo
Lloyd Mulenga
Andrew Silumesii
David Maman
Cheryl Johnson
author_sort Tina Chisenga
collection DOAJ
description Background Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on people’s movement, HIV service delivery was affected. Objectives To assess the impact of COVID-19 on HIV service delivery in Zambia by comparing uptake of HIV services before and during COVID-19. Methods We used repeated cross-sectional quarterly and monthly data on HIV testing, HIV positivity rate, people living with HIV initiating ART and use of essential hospital services from July 2018 to December 2020. We assessed quarterly trends and measured proportionate changes comparing periods before and during COVID-19 divided into three different comparison time frames: (1) annual comparison 2019 versus 2020; (2) April to December 2019 versus same period in 2020; and (3) Quarter 1 of 2020 as base period versus each of the other quarters of year 2020. Results Annual HIV testing dropped by 43.7% (95%CI 43.6–43.7) in 2020 compared to 2019 and was similar by sex. Overall, annual recorded number of newly diagnosed PLHIV fell by 26.5% (95% CI 26.37–26.73) in 2020 compared to 2019, but HIV positivity rate was higher in 2020, 6.44% (95%CI 6.41–6.47) compared to 4.94% (95% CI 4.92–4.96) in 2019. Annual ART initiation dropped by 19.9% (95%CI 19.7–20.0) in 2020 compared to 2019 while use of essential hospital services dropped during the early months of COVID-19 April to August 2020 but picked up later in the year. Conclusion While COVID-19 had a negative impact on health service delivery, its impact on HIV service delivery was not huge. HIV policies that were implemented before COVID-19 on testing made it easier to adopt COVID-19 control measures and to continue providing HIV testing services without much disruption.
first_indexed 2024-03-08T13:08:42Z
format Article
id doaj.art-c307a4123e1448d3a68c7dd5c59a0c4c
institution Directory Open Access Journal
issn 1654-9880
language English
last_indexed 2024-03-08T13:08:42Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Global Health Action
spelling doaj.art-c307a4123e1448d3a68c7dd5c59a0c4c2024-01-18T15:58:23ZengTaylor & Francis GroupGlobal Health Action1654-98802023-12-0116110.1080/16549716.2023.21759922175992Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilienceTina Chisenga0Menard Chihana1Paul Chishimba2Lastone Chitembo3Lloyd Mulenga4Andrew Silumesii5David Maman6Cheryl Johnson7Department of Communicable DiseasesWorld Health Organization, Global HIV, Hepatitis and STI ProgrammesDepartment of Monitoring and EvaluationWorld Health OrganizationUniversity Teaching HospitalDepartment of Monitoring and EvaluationWorld Health Organization, Global HIV, Hepatitis and STI ProgrammesWorld Health Organization, Global HIV, Hepatitis and STI ProgrammesBackground Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on people’s movement, HIV service delivery was affected. Objectives To assess the impact of COVID-19 on HIV service delivery in Zambia by comparing uptake of HIV services before and during COVID-19. Methods We used repeated cross-sectional quarterly and monthly data on HIV testing, HIV positivity rate, people living with HIV initiating ART and use of essential hospital services from July 2018 to December 2020. We assessed quarterly trends and measured proportionate changes comparing periods before and during COVID-19 divided into three different comparison time frames: (1) annual comparison 2019 versus 2020; (2) April to December 2019 versus same period in 2020; and (3) Quarter 1 of 2020 as base period versus each of the other quarters of year 2020. Results Annual HIV testing dropped by 43.7% (95%CI 43.6–43.7) in 2020 compared to 2019 and was similar by sex. Overall, annual recorded number of newly diagnosed PLHIV fell by 26.5% (95% CI 26.37–26.73) in 2020 compared to 2019, but HIV positivity rate was higher in 2020, 6.44% (95%CI 6.41–6.47) compared to 4.94% (95% CI 4.92–4.96) in 2019. Annual ART initiation dropped by 19.9% (95%CI 19.7–20.0) in 2020 compared to 2019 while use of essential hospital services dropped during the early months of COVID-19 April to August 2020 but picked up later in the year. Conclusion While COVID-19 had a negative impact on health service delivery, its impact on HIV service delivery was not huge. HIV policies that were implemented before COVID-19 on testing made it easier to adopt COVID-19 control measures and to continue providing HIV testing services without much disruption.http://dx.doi.org/10.1080/16549716.2023.2175992covid-19hivarthealth service deliveryhiv testing services
spellingShingle Tina Chisenga
Menard Chihana
Paul Chishimba
Lastone Chitembo
Lloyd Mulenga
Andrew Silumesii
David Maman
Cheryl Johnson
Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
Global Health Action
covid-19
hiv
art
health service delivery
hiv testing services
title Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
title_full Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
title_fullStr Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
title_full_unstemmed Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
title_short Maintaining HIV testing and treatment services in Zambia during COVID-19: a story of success and resilience
title_sort maintaining hiv testing and treatment services in zambia during covid 19 a story of success and resilience
topic covid-19
hiv
art
health service delivery
hiv testing services
url http://dx.doi.org/10.1080/16549716.2023.2175992
work_keys_str_mv AT tinachisenga maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT menardchihana maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT paulchishimba maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT lastonechitembo maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT lloydmulenga maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT andrewsilumesii maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT davidmaman maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience
AT cheryljohnson maintaininghivtestingandtreatmentservicesinzambiaduringcovid19astoryofsuccessandresilience